期刊文献+

伴高危因素且未发生淋巴结转移的T_(1-2)期乳腺癌术后患者放疗疗效及预后分析 被引量:6

Radiotherapy efficacy and prognosis of patients with stage T_(1-2) breast cancer with high risk factors without lymph node metastasis
下载PDF
导出
摘要 目的:探讨术后放疗对T_(1-2)期N0伴有脉管癌栓、神经侵犯、病灶多灶性、侵及周围脂肪组织等高危因素的乳腺癌患者的疗效及预后的影响。方法:选取2009年01月至2014年01月在我院行乳腺癌改良根治术后放疗的患者共100例,随机分为观察组和对照组,观察组给予胸壁及锁骨上下野放疗,对照组不行放疗,比较两组患者局部复发率、远处转移率、2年生存率、3年生存率。结果:随访3年,观察组的2年局部复发率与对照组比较差异无统计学意义(P>0.05);观察组2年远处转移率低于对照组,差异有统计学意义(P<0.05);观察组的3年局部复发率、远处转移率均明显低于对照组,差异具有统计学意义(P<0.05);观察组的2年、3年生存率高于对照组,但差异无统计学意义(P>0.05)。结论:对于低危乳腺癌患者中具有高危因素给予选择性行胸壁及锁骨上下野放疗,可降低局部复发率及远处转移率。 Objective :To investigate the effect of postoperative radiotherapy on breast cancer patients with T1- 2N0 associated with vascular thrombosis, nerve invasion, multifocal lesions,invasion of surrounding adipose tissue. Meth- ods:A total of 100 patients were randomly divided into the observation group and the control group. The observation group was given chest and supraclavicular radiotherapy, and the control group was not treated with radiotherapy. The two groups of patients with local recurrence rate, distant metastasis rate,2 - year and 3 - year survival rates were compared. Results : There was no significant difference in the 2 - year recurrence rate between the two groups ( P 〉 0.05 ). 2 - year distant metastasis rate of observation group was lower than control. The difference was statistically significant ( P 〈 0.05 ). The 3 - year recurrence rate and distant metastasis rate of the observation group were signifi- cantly lower than those of the control group ( P 〈 0.05 ). The 2 - year and 3 - year survival rates of the observation group were higher than those of the control group ( P 〉 0.05 ). Conclusion : For low - risk breast cancer patients with high risk factors, to give selective thoracic wall tangential field and supraclavicular radiotherapy, can reduce the chance of local recurrence and distant metastasis probability.
作者 向东华 齐创 李银枝 崔雁飞 Xiang Donghua;Qi Chuang;Li Yinzhi;Cui Yanfei(Department of Oncology,the Central Hospital of Enshi Autonomous Prej~cture,Hubei Enshi 445000,China)
出处 《现代肿瘤医学》 CAS 2018年第13期2051-2053,共3页 Journal of Modern Oncology
关键词 乳腺癌改良根治术 放射治疗 危险因素 预后 improved radical surgery- of breast cancer radiation therapy risk factors prognosis
  • 相关文献

参考文献6

二级参考文献128

  • 1惠周光,余子豪.我国乳腺癌改良根治术后放疗现状的调查分析[J].中华放射肿瘤学杂志,2005,14(6):471-475. 被引量:41
  • 2吴君心,余子豪,赵清正,郑天荣,陆丽丽.表皮生长因子受体与乳腺癌术后放疗后复发的相关性[J].实用肿瘤杂志,2005,20(6):522-524. 被引量:1
  • 3周卫兵,冯炎,陈佳艺,邵志敏.术后放疗在伴有腋窝淋巴结1~3个转移的T1~T2期乳腺癌中的作用[J].中华放射肿瘤学杂志,2006,15(5):396-400. 被引量:12
  • 4王准,封巍,刘冠,郑晓,王跃珍.88例早期乳腺癌术后胸壁复发的多因素分析[J].实用肿瘤杂志,2006,21(5):453-456. 被引量:9
  • 5KUNKLER I H, CANNEY P, VAN TIENHOVEN G, et al. Elucidating the role of chest wall irradiation in "intermediate-risk" breast cancer: The MRC/ EORTC/SUPREMO trial[J]. Clin Oncol, 2008, 20(1): 31-34.
  • 6KATZ A, STROM E A, BUCHHOLZ T A, et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation[J].J Clin Oncol, 2000, 18(15): 2817-2827.
  • 7RECHT A, GRAY R, DAVIDSON N E, et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group[J]. J Chin Oncol, 1999, 1 7(6): 1689-1700.
  • 8TAGHIAN A, JEONG J H, MAMOUNAS E, et al. Patterns of Iocoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials[J].J Clin Oncol, 2004, 22(21): 4237-4239.
  • 9NIELSEN H M, OVERGAARD M, GRAU C, et al. Loco-regional recurrence after mastectomy in high-risk breast cancer-risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials [J]. Radiother Oncol, 2006, 79(2): 147-155.
  • 10RAGAZ J, OLIVOTTO I A, SPINELLI J J, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial[J]. J Natl Cancer Inst, 2005, 97(2): 116-126.

共引文献32

同被引文献65

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部